Sunil Kumar

6PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 12, 2025
Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers.

Joshua Hutcheson, David Conway, Sunil Kumar

|Feb 25, 2023
Analytical Validation of NavDx, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Cancers.

Alicia Gunning, Sunil Kumar, Cassin Kimmel Williams

|Mar 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Christine H Chung, Jiannong Li, Conor E Steuer

|May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.

Bhishamjit S Chera, Sunil Kumar, Brian T Beaty

|Dec 12, 2018
Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ.

Sunil Kumar, Daniel Lindsay, Q Brent Chen

Pageof 1